MHRA stated: ‘no link can currently be made between the girl’s death and the vaccine’
The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a drug alert to the healthcare community advising them of the recall of the human papillomavirus (HPV) vaccination batch quarantined yesterday following the death of a 14-year-old girl.
The recall is being voluntarily carried out by GlaxoSmithKline (GSK), the manufacturer of the HPV vaccine Cervarix, as a precautionary measure while further investigations into the girl’s death are conducted by the MHRA. Healthcare professionals administering the vaccine have being asked to return any unused stock of this batch to GSK.
However, MHRA has stated that the safety of the vaccine is not in question and no link can currently be made between the girl’s death and the vaccine. The national HPV vaccination programme will continue as there are no supply issues associated with Cervarix. New stock is readily available.
Comment from Leslie
Hmmm- somehow this strikes me as being not unlike a virus – it mutates and moves on.